Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival, L. Barbier, O. Turrini, E. Grégoire, F. Viret, Y.-P. Le Treut and J.-R. Delpero, Volume 13, Issue 1, 2011, pp. 64–69.
In the above paper, the legend for Figure 2D was incorrect. The correct figure and legend are published below.
Figure 2.
Survival curves for all patients and for resected and non-resected patients. The tables under each graph give the number at risk. (D) Survival of patients with R0 vs. R1 margins. Median survival is 20 months (range: 2–109 months) in R0 patients and 14 months (range: 4–47 months) in R1 patients